WOW.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Is Eli Lilly's Latest Deal a Gamechanger? - AOL

   www.aol.com/finance/eli-lillys-latest-deal-game...

   At a forward price-to-earnings (P/E) ratio of 56.7, Lilly's stock is a bit pricey compared to the broader market. The forward P/E of the S&P 500 is roughly 20 right now.

3. Eli Lilly CEO: 'I think a bet on Lilly is to bet we can keep ...

   www.aol.com/finance/eli-lily-ceo-think-bet...

   Eli Lilly CEO Dave Ricks discusses the hot GLP-1 space and how ... Click here for in-depth analysis of the latest health industry news and events impacting stock prices. Show comments. Advertisement.

4. Is This Trend a Threat to Eli Lilly's Weight Loss Drug ... - AOL

   www.aol.com/trend-threat-eli-lillys-weight...

   Eli Lilly (NYSE: LLY) shares have soared more than 87% over the past year, making this player look more like a growth stock than a slower-paced but steady pharmaceutical stock. Lilly sells a broad ...

5. Eli Lilly and Company - Wikipedia

   en.wikipedia.org/wiki/Eli_Lilly_and_Company

   Eli Lilly and Company Company type Public Traded as NYSE: LLY S&P 100 component S&P 500 component ISIN US5324571083 Industry Pharmaceutical Founded 1876 ; 148 years ago (1876) Founder Eli Lilly Headquarters Indianapolis, Indiana, U.S. Key people David A. Ricks (Chair, President, & CEO) Anat Ashkenazi (CFO) Products Pharmaceutical drugs Revenue US$ 34.12 billion (2023) Operating income US$6.46 ...

6. These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now

   www.aol.com/finance/2-words-explain-why-eli...

   Here's why they make this stock worth a buy. The latest-earnings update has a lot to like Lilly's revenue rose by 26% year over year in the first quarter, reaching more than $8.7 billion.

7. If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago ...

   www.aol.com/youd-invested-10-000-eli-144126396.html

   If you'd invested $10,000 in Eli Lilly stock five years ago, you would have $65,900 today. That's a gain worthy of a top growth player. Lilly managed to draw the attention of a wide range of ...

8. Weight-loss drug drives Eli Lilly to raise 2024 sales ... - AOL

   www.aol.com/news/eli-lilly-lifts-profit-view...

   (Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2 billion on Tuesday, lifting ...

9. ImClone Systems - Wikipedia

   en.wikipedia.org/wiki/ImClone_Systems

   ImClone's stock price dropped sharply at the end of 2001 when its drug Erbitux, an experimental monoclonal antibody, failed to get the expected Food and Drug Administration (FDA) approval. It was later revealed by the U.S. Securities and Exchange Commission that numerous executives sold their stock before the announcement of the decision after ...